Bank Of America Corp Imv Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.45 $560 - $1,450	-1,000 Reduced 50.0%	1,000 $0
Q1 2022 May 16, 2022	SELL	$1.07 - $1.5 $16,375 - $22,956	-15,304 Reduced 88.44%	2,000 $2,000
Q4 2021 Feb 08, 2022	SELL	$1.22 - $1.78 $10,607 - $15,477	-8,695 Reduced 33.44%	17,304 $21,000
Q3 2021 Nov 15, 2021	BUY	$1.35 - $2.16 $31,048 - $49,677	22,999 Added 766.63%	25,999 $43,000
Q2 2021 Sep 13, 2021	BUY	$2.12 - $3.24 $6,360 - $9,720	3,000 New	3,000 $6,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.